Kolexia
Zoubir Mustapha Oncologie médicale
Zoubir Mustapha
Oncologie médicale
Clcc Institut Curie
Paris, France
55 Activités
503 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Carcinomes Récidive tumorale locale Tumeurs de l'anus Métastase tumorale Diarrhée Leucémies Leucémie chronique lymphocytaire à cellules B Leucémie lymphoïde

Collaborateurs

Voir plus
Menard Jean
Menard Jean
Hôpital privé des Peupliers, Paris, France
Buecher Bruno
Buecher Bruno
Clcc Institut Curie, Paris, France
Samalin Scalzi Emmanuelle
Samalin Scalzi Emmanuelle
Icm Montpellier, Montpellier, France
Le Tourneau Christophe
Le Tourneau Christophe
Clcc Institut Curie, Paris, France

Industries

Voir plus
Pfizer
4 collaboration(s)
Dernière en 2021
MSD
1 collaboration(s)
Dernière en 2023
Merck-Serono
1 collaboration(s)
Dernière en 2020
Sanofi
1 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Epitopes-HPV02: Assessment of the Clinical Value of a Docetaxel, Cisplatin and 5-fluorouracil (DCF) Strategy Adapted to Patients for the Management of Metastatic or Locally Advanced Anal Resistant Radiochemotherapy Squamous Cell Anal Carcinoma.
Essai Clinique (CHU Besançon)   10 mai 2022
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.
European journal of cancer (Oxford, England : 1990)   04 janvier 2022
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
Therapeutic advances in medical oncology   04 décembre 2020
Challenges for the implementation of high-throughput testing and liquid biopsies in personalized medicine cancer trials.
Personalized medicine   20 novembre 2019
The antivenom efficacy against a viper bite without medical treatment for 3 days: a case report.
Medecine et sante tropicales   11 décembre 2018
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
The Lancet. Oncology   02 juillet 2018
Docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD Groups (Epitopes-HPV02 study)
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC cancer   25 août 2017
A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974): A Phase 1b Trial of Dinaciclib in Combination With Rituximab in Subjects With Relapsed and Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Essai Clinique (Merck & Co.)   09 février 2015